75 results
Page 2 of 4
8-K
EX-99.3
z17ohd8l5tqj5
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.1
oqsl7best8zdj5
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
jyb4o kb7
29 Jul 22
Prospectus supplement
4:06pm
8-K
EX-99.1
9feaghc qjrf0400p4k
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
k5gboabomtx
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.1
1pyg bh14w7zze
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
425
rlb7wr vu16
27 Apr 22
Business combination disclosure
5:26pm
8-K
EX-99.1
4o0v7n f4kg4fsv
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
uueyvq6b c213tz3x4
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.1
9z78ezahkwp m3s
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
yy6x37tr67 6kgnamd8
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
j9u4q2 o3m8as7
5 Aug 21
Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
4:09pm